Pilot Study on the Usefulness of 3,4-diaminopyridine in the Treatment of Botulism

NCT01441557 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Botulism

Interventions

DRUG: 3,4-diaminopyridine

Sponsor

Centre Hospitalier Universitaire, Amiens